All guidelines for kidney disease screening include at least an annual measurement of serum creatinine, estimating the glomerular filtration rate (eGFR) using standardized formulas, and urine albumin-creatinine ratio (UACR) starting at the time of diagnosis of T2DM and 5 years after the onset in T1DM (17). This evidence concerns the gene ALB and kidney disorder.